AstraZeneca beats by $0.22, beats on revenues

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (NYSE:AZN) Q2 core EPS of $1.30, beats by $0.22.

Core operating profit decline 1% to $2.03B.

Revenue +4% to $6.45B, topping consensus of $6.24B.

The company revised FY14 Core EPS guidance to decrease in low double digits at CER, revenue in line at CER from FY13.

The company declared interim dividend of $0.90.